Bicycle Therapeutics Has Significant Upside Potential (NASDAQ:BCYC) TOPICS:Fashion Posted By: Advance February 28, 2022 Bicycle Therapeutics’ BT8009 and BT7480 candidates made good progress. Read more to see why BCYC could be a strong oncology stock investors can benefit from.